Company Analysis
Sign in

Glaukos Corporation (GKOS)

NYSE: GKOS · Surgical & Medical Instruments & Apparatus · Aliso Viejo, CA · filing with the SEC since 2002
Full chart Alerts Compare
Grade6.0
◀ Past 6.3● Present 6.4▶ Future 5.2
1 est.
OverviewBusinessFinancialsGradeForecastSentimentOwnershipPeopleFilingsPatents Chart

Patents

US patents through Dec 31, 2025 · PatentsView, from the USPTO’s Open Data Portal · read Oct 27, 2026

163 patents granted to the 4 names below, as the owner printed on each patent when it was granted. A later sale, a lapse or an expiry is not read, so this is what was granted to Glaukos Corporation’s names, not what it holds today.

Patents granted
163
155 utility, 8 design, 1976 to Dec 31, 2025
Granted in 2025
18
Against 13 in 2024 and 8 in 2023
Applications published
212
22 of them in 2025
Names they are printed under
4
its own name, a subsidiary
By yearGrantedApplications published
'11'12'13'14'15'16'17'18'19'20'21'22'23'24'25
Each pair is one calendar year. Applications are published about eighteen months after filing, so the newest years read low.
What they are aboutgrants since 2021
Medical technology42
Pharmaceuticals10
Organic fine chemistry1
The main technology area of each patent, in the World Intellectual Property Organization’s 35 fields.
Under which name4 counted
Glaukos Corporation its own name
US, as the owner printed on each patent
113 granted
40 published
GLAUKOS CORPORATION its own name
named as the applicant on its applications, in US
0 granted
86 published
Avedro, Inc. a subsidiary
US, as the owner printed on each patent
50 granted
29 published
Avedro, Inc. a subsidiary
named as the applicant on its applications, in US
0 granted
57 published
Newest grantseach row opens the USPTO’s own copy
GrantedPatentTitleFieldOwner as printed
Nov 25, 202512,478,504Drug eluting ocular implantsMedical technologyGlaukos Corporation
Nov 25, 202512,478,503Implants with controlled drug delivery features and methods of using sameMedical technologyGlaukos Corporation
Oct 28, 202512,453,653Materials and methods for punctal plugsMedical technologyGlaukos Corporation
Oct 28, 202512,453,652Systems and methods treating for corneal ectatic disordersMedical technologyAvedro, Inc.
Sep 30, 202512,427,062Systems and methods for cross-linking treatments of an eyeMedical technologyAvedro, Inc.
Sep 30, 202512,427,057Controlled drug delivery ocular implants and methods of using sameMedical technologyGlaukos Corporation
Sep 23, 202512,420,072Systems and methods for cross-linking treatments of an eyeMedical technologyAvedro, Inc.
Sep 23, 202512,419,783Drug eluting ocular implantPharmaceuticalsGlaukos Corporation
Sep 16, 202512,414,938Ophthalmic topical cream compositions and methodsPharmaceuticalsGlaukos Corporation
Sep 16, 202512,414,798Systems and methods for delivering multiple ocular implantsMedical technologyGlaukos Corporation
Newest applications publishedan application is a clue, never a plan
PublishedApplicationTitleFieldOwner as printed
Dec 25, 20252025/0387372OPHTHALMIC TOPICAL CREAM COMPOSITIONS AND METHODSPharmaceuticalsGLAUKOS CORPORATION
Dec 25, 20252025/0387260SYSTEMS AND METHODS TREATING FOR CORNEAL ECTATIC DISORDERSMedical technologyAvedro, Inc.
Dec 25, 20252025/0387138METHODS FOR DELIVERING MULTIPLE OCULAR IMPLANTSMedical technologyGLAUKOS CORPORATION
Dec 18, 20252025/0381376SYSTEMS AND METHODS FOR CROSS-LINKING TREATMENTS OF AN EYEMedical technologyAvedro, Inc.
Dec 11, 20252025/0376450COMPOUNDS AND COMPOSITIONS FOR EYE TREATMENTSPharmaceuticalsAvedro, Inc.
Dec 11, 20252025/0375314DRUG ELUTING OCULAR IMPLANTPharmaceuticalsGLAUKOS CORPORATION
Nov 13, 20252025/0346578BIS(DIAZIRINE) DERIVATIVES AS PHOTO-CROSSSLINKER FOR TREATING CORNEAL ECTATIC DISORDERSOrganic fine chemistryAvedro, Inc.
Oct 9, 20252025/0312190DRUG ELUTING OCULAR IMPLANTS AND METHODS OF TREATING AN OCULAR DISORDERMedical technologyGLAUKOS CORPORATION
Sep 18, 20252025/0288461SYSTEM FOR DELIVERING MULTIPLE OCULAR IMPLANTSMedical technologyGLAUKOS CORPORATION
Aug 14, 20252025/0255963FORMULATIONS FOR EYE TREATMENTSPharmaceuticalsAvedro, Inc.
What it applied for, 2024 to 2025: Medical technology 24 · Pharmaceuticals 11 · Organic fine chemistry 1.

A patent is counted where the owner printed on it when it was granted carries the company’s own name, a former name, the name of a subsidiary its annual report lists, or its own name with a patent-holding phrase (Technology Licensing, Intellectual Property and the like), once the legal form, case and punctuation are set aside, and prints a country that name counts in. PatentsView’s data are published under the Creative Commons Attribution 4.0 licence. Source: PatentsView's granted patents and pre-grant publications, disambiguated, from the USPTO's Open Data Portal, through Dec 31, 2025, read Oct 27, 2026.

SI Assistanton GKOS · research, not advice